BFLY · XBRL financial data

Butterfly Network financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (BFLY's year ends in late December)

In thousands of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue from contracts with customers46,25262,56573,39065,90082,05697,610
Cost of revenue107,47545,51133,93049,04433,225—
Cost of goods and services sold———49,04433,22551,876
Gross profit(61,223)17,05439,46016,85648,83145,734
Research and development49,73874,46189,12155,61637,80036,262
General and administrative24,39585,71783,47149,61339,81039,235
Total operating expenses100,396209,782232,480162,466123,242132,149
Operating income (loss)(161,619)(192,728)(193,020)(145,610)(74,411)(86,415)
Interest income2852,5733,3847,4505,0205,911
Interest expense1,141651201,2611,490
Other income (expense)(231)(2,577)98(2)(13)2,768
Income tax expense (benefit)391214282(32)110
Net income (loss)(162,745)(32,409)(168,723)(133,700)(72,492)(77,064)
Earnings per share, basic USD per share(26.87)(0.19)(0.84)(0.65)(0.34)(0.31)
Earnings per share, diluted USD per share(26.87)(0.19)(0.84)(0.65)(0.34)(0.31)
Weighted average shares, basic thousands of shares6,057173,810199,848205,386211,683247,124
Weighted average shares, diluted thousands of shares6,057173,810199,848205,386211,683247,124
  • † Share count changed about 29x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (BFLY's year ends in late December)

In thousands of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Cash and cash equivalents60,206422,841162,561134,43788,775150,489
Marketable securities——75,250———
Accounts receivable5,75211,93614,68513,41820,79326,744
Inventory25,80536,24359,97073,02270,78961,389
Prepaid and other current assets2,99813,3849,4897,5716,7098,418
Total current assets318511,904357,137231,263192,613249,103
Property and equipment, net6,87014,70331,33125,32119,51816,587
Right-of-use asset—24,08321,56715,67514,23312,652
Total assets414,652571,965417,570304,274256,082296,533
Accounts payable16,4005,7987,2115,0904,2505,442
Total current liabilities2,80449,82951,32944,27148,21565,117
Lease liability, non-current—27,69029,96622,83520,39817,721
Total liabilities153,399124,27492,21084,22187,250100,554
Accumulated deficit(132,205)(427,215)(595,938)(729,638)(802,130)(879,194)
Total stockholders' equity5,000447,691325,360220,053168,832195,979
Total liabilities and equity414,652571,965417,570304,274256,082296,533
  • † Share count changed about 29x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (BFLY's year ends in late December)

In thousands of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Net income (loss)(162,745)(32,409)(168,723)(133,700)(72,492)(77,064)
Stock-based compensation11,00447,79842,53127,48021,03223,435
Depreciation and amortization1,3162,0905,9358,7008,9006,700
Net cash from operating activities(81,700)(189,187)(169,115)(98,820)(41,707)(12,700)
Purchases of property and equipment2,3767,87718,3025,7832,6943,348
Net cash from investing activities(2,376)(9,870)(93,779)70,414(2,658)(3,348)
Proceeds from issuing common stock———0081,006
Repayments of long-term debt—4,366————
Net cash from financing activities54,280565,6922,881228(1,495)77,762
Net change in cash(29,796)366,635(260,013)(28,178)(45,860)61,714
  • † Share count changed about 29x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3844 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Butterfly Network122,30132,598(2,266)*not reported10.3 quarters 10-QSep 30, 2026
Pulse Biosciences101,620434(18,709)*71.3M5.4 quarters 10-QJun 30, 2026
Orthopediatrics17,14172,6614,506*26.1M— 10-QSep 30, 2026
Ceribell41,98929,341(13,078)*38.8M7.8 quarters 10-QSep 30, 2026
EBR Systems59,3502,637(17,194)*75.3M5.0 quarters 10-QJun 30, 2026
Delcath Systems47,52129,1335,712*34.7M— 10-QJun 30, 2026
Axogen328,88875,83416,536*59.7M— 10-QSep 30, 2026
Angiodynamics33,97380,915(15,330)42.1M2.2 quarters 10-QAug 31, 2026
Outset Medical35,00531,635(9,635)*18.8M15.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.